SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's Laboratories launches Ramelteon Tablets in US Market

23 Jul 2019 Evaluate

Dr. Reddy's Laboratories has launched Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The company’s Ramelteon Tablets, are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000. According to IQVIA Health, the Rozerem brand had U.S. sales of approximately $91.3 million MAT for the most recent twelve months ending in May 2019.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1369.20 22.95 (1.70%)
03-Jul-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1908.75
Dr. Reddys Labs. 1369.20
Cipla 1464.25
Zydus Lifesciences 1112.00
Lupin 2447.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: